MENU
GLPG
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Galapagos (GLPG) Ownership - Who owns Galapagos?
Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
Generaal De Wittelaan L11 A3
Phone
+32 15342900
Employees
1123
Web
https://www.glpg.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.59B
P/E Ratio
53.70
Total Cash
3.34B
Projected Growth
N/A
Total Debt
11.47M
Revenue
260.09M
Risk (Beta)
0.30
Dividend Yield
N/A
Total Cash/Share
50.67
Total Debt/Equity
N/A
Revenue/Share
4.57 USD as % of share price
Fundamentals
GLPG
Capitalization
1.59B
P/E Ratio
53.70
Risk (Beta)
0.30
Dividend Yield
N/A
Total Cash
3.34B
Total Cash/Share
50.67
Total Debt
11.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
4.57%
Revenue
260M
ROE
N/A
Book Value
2.86B
P/B Ratio
0.51
Cash Flow
N/A
Earnings
3.13
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
294M
Current Ratio
10.13
Current Revenue Per Employee
92645.51
Dividends Per Share - Security
N/A
EBITDA
-63.34M
Float
N/A
Float - Current
N/A
Gross Income Margin
99.97
Revenue To Assets
4.79
Shares Held By Institutions
432M
Shares Outstanding - Current
65.9M
Total Liabilities
1.31B
Total Volume MTD
N/A
Value
-1
Gain YTD
-11.491
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a manufacturer of pharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
Generaal De Wittelaan L11 A3
Phone
+32 15342900
Employees
1123
Web
https://www.glpg.com